Literature DB >> 12116238

Clinical, cytogenetic, and molecular findings in 45,X/47,XX,+18 mosaicism: clinical report and review of the literature.

Regine Schubert1, Thomas Eggermann, Cornelia Hofstaetter, Barbara von Netzer, Gisela Knöpfle, Gesa Schwanitz.   

Abstract

We report cytogenetic and molecular findings performed in a patient with double mosaic aneuploidy. Chromosome analysis of amniotic fluid cells from a 17-week-old fetus was performed because of advanced maternal age. Two karyotypes were detected: 45,X and 47,XX,+18 (50:50%). The same cell lines were determined in uncultured and cultured amniocytes of a second amniotic fluid sample, in fetal lymphocytes, and in uncultured and cultured cells of achilles tendon by conventional cytogenetics and fluorescence in situ hybridization (FISH). In the different investigated tissues, the percentage of cells with 45,X karyotype ranged from 20-99% and the percentage of cells with 47,XX,+18 ranged from 1-80%. The pregnancy was terminated at 22 + 0 weeks because of a severe cardiac malformation. Pathologic examination showed a fetus with aspects typical for manifestation of trisomy 18 and monosomy X, especially in the internal organs. The parent and cell stage of origin was determined by short tandem repeat typing and revealed a maternal meiotic division error that led to trisomy 18, as well as a somatic loss of a paternal sex chromosome. Only two other patients with the same mosaicism have been reported so far. Genetic counseling and prognosis remains challenging. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12116238     DOI: 10.1002/ajmg.10442

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  4 in total

1.  Sporadic aneuploidy in PHA-stimulated lymphocytes of Turner's syndrome patients.

Authors:  Orit Reish; Nirit Brosh; Rima Gobazov; Malka Rosenblat; Vitalia Libman; Maya Mashevich
Journal:  Chromosome Res       Date:  2006-07-12       Impact factor: 5.239

2.  Dual diagnoses in 152 patients with Turner syndrome: Knowledge of the second condition may lead to modification of treatment and/or surveillance.

Authors:  Kelly L Jones; Erin A McNamara; Mauro Longoni; Danny E Miller; Mersedeh Rohanizadegan; Laura A Newman; Frances Hayes; Lynne L Levitsky; Betty L Herrington; Angela E Lin
Journal:  Am J Med Genet A       Date:  2018-08-06       Impact factor: 2.802

3.  Prenatal diagnosis of a trisomy 7/trisomy 13 mosaicism.

Authors:  Karin Huijsdens-van Amsterdam; Daniela Qcm Barge-Schaapveld; Inge B Mathijssen; Mariëlle Alders; Eva Pajkrt; Alida C Knegt
Journal:  Mol Cytogenet       Date:  2012-01-27       Impact factor: 2.009

4.  Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples.

Authors:  Tracy Futch; John Spinosa; Sucheta Bhatt; Eileen de Feo; Richard P Rava; Amy J Sehnert
Journal:  Prenat Diagn       Date:  2013-06       Impact factor: 3.050

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.